Clinically relevant drug interactions with multikinase inhibitors: a review
Sign Up to like & getrecommendations! Published in 2019 at "Therapeutic Advances in Medical Oncology"
DOI: 10.1177/1758835918818347
Abstract: Multikinase inhibitors (MKIs), including the tyrosine kinase inhibitors (TKIs), have rapidly become an established factor in daily (hemato)-oncology practice. Although the oral route of administration offers improved flexibility and convenience for the patient, challenges arise… read more here.
Keywords: drug interactions; mkis; multikinase inhibitors; drug ... See more keywords